Dave Stassen


NovoLogix remakes itself to tame bizarre drug pricing system

NovoLogix Inc. is not the easiest company to understand. But it does have a colorful past and an intriguing future. Once a $400 million force in the home-health care market, the former Ancillary Care Management has remade itself into a software-as-a-service company that focuses on helping payers manage claims relating to fast growing demand for […]